↓ Skip to main content

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

Overview of attention for article published in BMC Cancer, August 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 9,038)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
47 news outlets

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
89 Mendeley
Title
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
Published in
BMC Cancer, August 2020
DOI 10.1186/s12885-020-07252-y
Pubmed ID
Authors

S. J. Schraa, K. L. van Rooijen, D. E. W. van der Kruijssen, C. Rubio Alarcón, J. Phallen, M. Sausen, J. Simmons, V. M. H. Coupé, W. M. U. van Grevenstein, S. Elias, H. M. Verkooijen, M. M. Laclé, L. J. W. Bosch, D. van den Broek, G. A. Meijer, V. E. Velculescu, R. J. A. Fijneman, G. R. Vink, M. Koopman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 15%
Student > Ph. D. Student 13 15%
Student > Master 8 9%
Other 7 8%
Student > Bachelor 5 6%
Other 7 8%
Unknown 36 40%
Readers by discipline Count As %
Medicine and Dentistry 23 26%
Biochemistry, Genetics and Molecular Biology 10 11%
Nursing and Health Professions 5 6%
Agricultural and Biological Sciences 4 4%
Unspecified 3 3%
Other 1 1%
Unknown 43 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 337. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2024.
All research outputs
#99,011
of 25,660,026 outputs
Outputs from BMC Cancer
#8
of 9,038 outputs
Outputs of similar age
#3,232
of 427,142 outputs
Outputs of similar age from BMC Cancer
#1
of 149 outputs
Altmetric has tracked 25,660,026 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,038 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,142 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 149 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.